MoneyWorks4Me

Hikal - Quaterly Results

04 Feb 2025 Evaluate
A minor change in the total revenue was seen in the December 2024 quarter. The total revenue for the quarter stood at Rs. 4477.00 millions against Rs. 4475.00 millions during year ago period.A slim rise of 6.79% was recorded in the Net profit for the quarter ended December 2024 to Rs. 173.00  millions  From Rs. 162.00 millions.Operating profit for the quarter ended December 2024 rose to 758.00 millions as compared to 649.00 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 4477.00 4475.00 0.04 13074.00 12704.00 2.91 17846.00 20230.30 -11.79
Other Income 36.00 1.00 3500.00 45.00 20.00 125.00 24.50 54.10 -54.71
PBIDT 758.00 649.00 16.80 2095.00 1746.00 19.99 2693.90 2624.70 2.64
Interest 187.00 142.00 31.69 573.00 411.00 39.42 563.70 481.00 17.19
PBDT 571.00 507.00 12.62 1522.00 1335.00 14.01 2130.20 2143.70 -0.63
Depreciation 332.00 290.00 14.48 967.00 853.00 13.36 1176.10 1090.10 7.89
PBT 239.00 217.00 10.14 555.00 482.00 15.15 954.10 1053.60 -9.44
TAX 66.00 55.00 20.00 149.00 126.00 18.25 259.00 269.80 -4.00
Deferred Tax 21.00 3.00 600.00 22.00 2.00 1000.00 -24.70 -35.00 -29.43
PAT 173.00 162.00 6.79 406.00 356.00 14.04 695.10 783.80 -11.32
Equity 247.00 247.00 0.00 247.00 247.00 0.00 246.60 246.60 0.00
PBIDTM(%) 16.93 14.50 16.74 16.02 13.74 16.59 15.10 12.97 16.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..